Opportunity Information: Apply for PA 19 090

The NIH Pathway to Independence Award (Parent K99/R00) is a two-phase NIH grant meant to help outstanding postdoctoral researchers move more quickly and securely into independent, tenure-track (or equivalent) faculty careers. Its central goal is to grow and sustain a strong pipeline of new NIH-supported investigators by funding the critical transition period when a researcher is shifting from mentored postdoctoral training to running an independent research program. In practice, the award supports a candidate first in a mentored phase (the K99 portion) and then, once they secure an eligible independent faculty position, in an independent phase (the R00 portion). This structure is intended to reduce the career gap that can occur between postdoctoral training and the first independent research grant, giving awardees a clearer runway to establish themselves, generate strong data, publish, and compete successfully for subsequent NIH funding.

This specific Funding Opportunity Announcement (PA-19-090) is tailored for applicants whose work involves what NIH classifies as a clinical trial but is still considered basic research. It is aimed at researchers proposing to lead independent basic experimental studies with humans, described in NIH guidance as "prospective basic science studies involving human participants." These are studies where human participants are prospectively assigned to conditions, meaning the investigator actively manipulates an independent variable (for example, assigning participants to different task conditions, exposures, stimuli, or experimentally controlled environments) and then measures biomedical or behavioral outcomes. The key point is that the purpose is to understand fundamental mechanisms or phenomena, not to test a product, treatment, or process with a direct practical application in mind. If the intent of the study is more applied, such as evaluating an intervention or product with a specific practical or translational goal, NIH directs applicants to use the companion announcement (PA-18-397) instead.

Eligibility in the posted summary spans a wide set of organizational applicant types across government, academic, nonprofit, and for-profit sectors. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations that are not federally recognized. It also includes public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in that nonprofit category listing); for-profit organizations (other than small businesses); and small businesses, along with other applicant categories NIH may allow under its general policies. The opportunity also explicitly highlights participation from institutions and organizations that serve specific communities, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

At the same time, NIH places clear limits on foreign involvement at the applicant-organization level. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, "foreign components" as defined in the NIH Grants Policy Statement are allowed, meaning a U.S.-based applicant institution can include certain types of well-justified foreign collaboration or activities under NIH rules, even though a foreign institution cannot be the primary applicant.

Administratively, this is a discretionary grant opportunity offered by the National Institutes of Health (NIH), listed under multiple CFDA numbers (93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.853, 93.865, 93.866, 93.867), reflecting that different NIH Institutes and Centers may participate and support awards under their missions. The posting notes an original closing date of 2020-05-07 and a creation date of 2018-11-28. The award ceiling and expected number of awards are not specified in the provided source data, which typically means applicants must refer to the full FOA text and relevant NIH Institute/Center participation details for budget structure, duration limits, and Institute-specific policies.

Overall, this K99/R00 FOA is best understood as a career acceleration mechanism for top postdoctoral candidates who are ready to build independence and who plan to run rigorous basic experimental studies in humans that meet the NIH clinical trial definition but are fundamentally mechanistic rather than applied. It funds both the final stage of mentored development and the initial launch of an independent lab or research program, with the explicit intent of producing competitive, long-term NIH-funded investigators.

  • The National Institutes of Health in the education, environment, health, income security and social services sector is offering a public funding opportunity titled "NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.853, 93.865, 93.866, 93.867.
  • This funding opportunity was created on 2018-11-28.
  • Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 19 090

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIH Pathway to Independence Award (Parent K99/R00) - Clinical Trial Required, Basic Experimental Studies with Humans (PA-19-090)

1) What is the NIH Pathway to Independence Award (K99/R00)?

The NIH Pathway to Independence Award (Parent K99/R00) is a two-phase NIH grant designed to help outstanding postdoctoral researchers transition more quickly and securely into independent, tenure-track (or equivalent) faculty careers. It supports a mentored postdoctoral phase (K99) followed by an independent phase (R00) once the awardee obtains an eligible independent faculty position.

2) What is the main purpose of this award?

The central goal is to strengthen the pipeline of new NIH-supported investigators by funding the critical career transition from mentored postdoctoral training to running an independent research program. The structure aims to reduce the gap between postdoctoral training and the first independent research grant by providing a clearer runway to establish independence, generate data, publish, and compete for later NIH funding.

3) What does "two-phase" mean in practice?

This award is split into:

  • K99 (Mentored phase): Supports the candidate while they are completing mentored postdoctoral research and career development.
  • R00 (Independent phase): Activates after the candidate secures an eligible independent faculty position, supporting the launch of their independent research program.

4) What Funding Opportunity Announcement (FOA) is described here?

The FOA referenced is PA-19-090. It is a specific version of the Parent K99/R00 tailored for applicants whose proposed work meets NIH's definition of a clinical trial but is considered basic research.

5) Who is this FOA intended for?

It is intended for postdoctoral researchers who are ready to move toward independence and who propose to lead independent basic experimental studies with humans that fall under NIH's clinical trial definition.

6) Why does this FOA mention "clinical trial" if the research is basic research?

NIH classifies certain prospective human studies as clinical trials when participants are assigned to conditions and outcomes are measured. PA-19-090 is specifically for cases where the study design meets the clinical trial definition, but the scientific intent is to understand fundamental mechanisms or phenomena (basic research), rather than to evaluate an applied intervention or product.

7) What kinds of studies does NIH describe as "prospective basic science studies involving human participants"?

These are studies where human participants are prospectively assigned to conditions, meaning the investigator actively manipulates an independent variable and then measures biomedical or behavioral outcomes. Examples of assignment/manipulation described include assigning participants to different task conditions, exposures, stimuli, or experimentally controlled environments, with the purpose of understanding underlying mechanisms.

8) What is the key distinction between this FOA and a more applied clinical trial?

The key distinction is the purpose of the study. Under this FOA, the goal is to understand fundamental mechanisms or phenomena. If the intent is more applied (for example, testing a product, treatment, or process with a practical or translational goal), NIH directs applicants to a companion announcement instead.

9) When should an applicant use the companion announcement PA-18-397 instead?

If the proposed study is more applied in intent, such as evaluating an intervention or product with a specific practical or translational aim, NIH indicates the companion FOA PA-18-397 should be used rather than PA-19-090.

10) What types of organizations are eligible to apply (as the applicant organization)?

The eligibility summary includes a broad range of U.S.-based organizational types across government, academic, nonprofit, and for-profit sectors. Eligible applicants include:

  • State governments; county governments; city or township governments
  • Special district governments
  • Independent school districts
  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • Federally recognized Native American tribal governments
  • Native American tribal organizations that are not federally recognized
  • Public housing authorities / Indian housing authorities
  • Nonprofits with or without 501(c)(3) status (as listed in the summary, excluding institutions of higher education in that nonprofit listing)
  • For-profit organizations (other than small businesses)
  • Small businesses
  • Other categories NIH may allow under its general policies

11) Does the opportunity encourage applications from specific institution types or communities?

Yes. The posting explicitly highlights participation from organizations that serve specific communities and other eligible entities, including:

  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Faith-based or community-based organizations
  • Regional organizations
  • Eligible federal agencies
  • U.S. territories or possessions

12) Are foreign organizations eligible to apply as the applicant organization?

No. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization under this opportunity.

13) Can a non-domestic component of a U.S. organization apply as the applicant?

No. The posting states that non-domestic components of U.S. organizations are not eligible to apply as the applicant organization.

14) Is any foreign involvement allowed at all?

Yes, in a limited way. While foreign institutions cannot be the primary applicant, the opportunity allows "foreign components" as defined in the NIH Grants Policy Statement. That means a U.S.-based applicant institution may include certain well-justified foreign collaboration or activities under NIH rules, even though a foreign organization cannot be the primary applicant.

15) What kind of grant mechanism is this?

This is described as a discretionary grant opportunity offered by the National Institutes of Health (NIH).

16) Which federal agency is offering this opportunity?

The opportunity is offered by the National Institutes of Health (NIH).

17) Why are multiple CFDA numbers listed for this opportunity?

Multiple CFDA numbers are listed (93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.853, 93.865, 93.866, 93.867) because different NIH Institutes and Centers may participate and support awards under their missions.

18) Are the award ceiling and expected number of awards provided in the summary?

No. The award ceiling and expected number of awards are not specified in the provided source data. In situations like this, applicants typically need to consult the full FOA text and relevant NIH Institute/Center participation details for budget structure, duration limits, and Institute-specific policies.

19) What dates are included in the posting summary?

The summary notes a creation date of 2018-11-28 and an original closing date of 2020-05-07.

20) What is the overall "best fit" profile for PA-19-090 based on the summary?

This FOA is best suited for top postdoctoral candidates who are ready to build independence and plan to conduct rigorous basic experimental studies in humans that meet NIH's clinical trial definition but are mechanistic rather than applied. It is positioned as a career acceleration mechanism that funds both the final mentored stage and the initial launch of an independent research program, with the intent of producing competitive, long-term NIH-funded investigators.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Environment, Health, Income Security and Social Services

Next opportunity: HEAL Initiative: Behavioral Research to Improve MAT: Behavioral and Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R61/R33 Clinical Trial Optional)

Previous opportunity: Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 19 090

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 19 090) also looked into and applied for these:

Funding Opportunity
Mentored Quantitative Research Development Award (Parent K25 - Independent Basic Experimental Studies with Humans Required) Apply for PA 19 089

Funding Number: PA 19 089
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required) Apply for PA 19 087

Funding Number: PA 19 087
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Basic Experimental Studies with Humans Required) Apply for PA 19 086

Funding Number: PA 19 086
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed) Apply for RFA EB 18 004

Funding Number: RFA EB 18 004
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $600,000
HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34- Clinical Trial Not Allowed) Apply for RFA DA 19 029

Funding Number: RFA DA 19 029
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $225,000
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) Apply for PAR 19 134

Funding Number: PAR 19 134
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $300,000
HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed) Apply for RFA DA 19 036

Funding Number: RFA DA 19 036
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $225,000
Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed) Apply for RFA MH 20 210

Funding Number: RFA MH 20 210
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $900,000
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) Apply for RFA OD 19 016

Funding Number: RFA OD 19 016
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required) Apply for RFA OD 19 018

Funding Number: RFA OD 19 018
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) Apply for RFA OD 19 015

Funding Number: RFA OD 19 015
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $200,000
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required Apply for PA 19 273

Funding Number: PA 19 273
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Apply for PAR 19 276

Funding Number: PAR 19 276
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $50,000
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Apply for PAR 19 274

Funding Number: PAR 19 274
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed) Apply for RFA MH 20 150

Funding Number: RFA MH 20 150
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed) Apply for RFA MH 20 145

Funding Number: RFA MH 20 145
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed) Apply for RFA NS 20 003

Funding Number: RFA NS 20 003
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $250,000
NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP-ENDURE) (R25 Clinical Trial Not Allowed) Apply for RFA NS 20 015

Funding Number: RFA NS 20 015
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) Apply for RFA OD 20 004

Funding Number: RFA OD 20 004
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: $200,000
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Apply for PA 20 142

Funding Number: PA 20 142
Agency: National Institutes of Health
Category: Education, Environment, Health, Income Security and Social Services
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 19 090", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: